AEON vs JNJ · P/E 0.0, $8.6M cap vs P/E 17, rev $49.37B
AEON Biopharma, Inc. (AEON) versus Johnson & Johnson (JNJ) — a side-by-side from cached financials, not a winner call.
AEON Biopharma, Inc. (AEON) is a biotechnology company listed on US.
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
AEON does not have a complete income-statement cache yet.
Latest reported JNJ revenue for 2026-06-28 was $49.37B. Net income was $10.77B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
AEON currently screens at market cap $8.6M and trailing P/E 0.0. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
Not investment advice. Open the AEON and JNJ stock pages for the full models.
Not investment advice.